Archive for April, 2017
Recent Rosacea Blog Posts
Allergan has announced the availability of the Rhofade Cream Savings Program, which is promoted as allowing access to a prescription of Rhofade for as little as $35. This out-of-pocket amount only applies if you have commercial insurance that covers Rhofade. If your insurance does not cover Rhofade `you may pay as little as $75′. The […]
I don’t know if rosacea sufferers really need another tetracycline variant, but Allergan has published some promising Phase III trial data for Sarecycline as a treatment for the lesions of moderate to severe acne. Whilst no longer being directly promoted as a treatment for rosacea (and indeed it is not clear if Allergan will be […]
Allergan’s Oxymetazoline based cream, Rhofade (oxymetazoline hydrochloride cream 1%) – for the treatment of the redness of rosacea is now generally available. Does it work to effectively and safely reduce the redness of rosacea? You have come to the right page to find out. Some Oxymetazoline History For rosacea sufferers it has been a long […]
Galderma are continuing to build out their rosacea portfolio, this time with a new series of anti-redness products in their Cetaphil range. We know that Galderma sees a future in the cosmetic realm, as well as pursuing the prescription treatment market. Cetainly Galderma see their Cetaphil range as a premium product, capable of generating profit […]
